TRANSLATE

The mm Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mm Hub cannot guarantee the accuracy of translated content. The mm and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

Niels Van de Donk | ESH MM 2018 | Plasma cell leukemia and extramedullary disease

Featured:

Niels van de DonkNiels van de Donk

Oct 5, 2018


4th International Conference on Multiple Myeloma, European School of Haematology, 5–7 October, Mandelieu, France

Niels Van de Donk talks about the main biological and clinical features of extramedullary plasmacytoma (EMP) and plasma cell leukemia (PCL) and how they relate to multiple myeloma.

English

Dutch

Plasma cell leukemia and extramedullary disease